Dissecting the Delhi HC’s Assessment of Diagnostic Processes Under Section 3(i) of the Patents Act
The Delhi HC has articulated a detailed interpretative understanding of the exclusion of diagnostic methods from patentability under Section 3(i) of the Patents Act. In three judgments passed in three different appeals (Natera, Sequenom, and Emd Millipore), the Court has laid down the manner in which the provision is to be understood and applied. The Court clarified that the manner in which the diagnosis is to be performed cannot be patented, whereas diagnostic tools, products, and devices can still be […]
